Advertisement
Screener

Beam Therapeutics Inc. (BEAM) Increase (Decrease) in Other Noncurrent Liabilities

2.8 / 5 stars · 68/120 Roast Me

Beam Therapeutics Inc. Increase (Decrease) in Other Noncurrent Liabilities

Beam Therapeutics Inc. (BEAM) reported Increase (Decrease) in Other Noncurrent Liabilities of $123.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-04

  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$11.00K.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $134.00K.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$91.00K, a 513.64% decline year-over-year.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$93.00K.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$330.00K, a 169.77% decline from fiscal 2024.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $473.00K.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$194.00K.
  • Beam Therapeutics Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$2.57M, a 243.60% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Noncurrent Liabilities 3 monthIncrease (Decrease) in Other Noncurrent Liabilities 3 month as first filedIncrease (Decrease) in Other Noncurrent Liabilities 6 monthIncrease (Decrease) in Other Noncurrent Liabilities 9 monthIncrease (Decrease) in Other Noncurrent Liabilities 12 month
2026-06-30-$11.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$123.00K
10-Q · filed 2026-08-04
$32.00K
derived: sum of 3 quarters · filed 2026-08-04
-$61.00K
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$134.00K
10-Q · filed 2026-05-07
$43.00K
derived: sum of 2 quarters · filed 2026-05-07
-$50.00K
derived: sum of 3 quarters · filed 2026-05-07
-$107.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$91.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$184.00K
derived: sum of 2 quarters · filed 2026-02-24
-$241.00K
derived: sum of 3 quarters · filed 2026-08-04
-$330.00K
10-K · filed 2026-02-24
2025-09-30-$93.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$150.00K
derived: sum of 2 quarters · filed 2026-08-04
-$239.00K
10-Q · filed 2025-11-04
-$217.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$57.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$146.00K
10-Q · filed 2026-08-04
-$124.00K
derived: sum of 3 quarters · filed 2026-08-04
-$212.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$89.00K
10-Q · filed 2026-05-07
-$67.00K
derived: sum of 2 quarters · filed 2026-05-07
-$155.00K
derived: sum of 3 quarters · filed 2026-05-07
-$195.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$66.00K
derived: sum of 2 quarters · filed 2026-02-24
-$106.00K
derived: sum of 3 quarters · filed 2026-02-24
$473.00K
10-K · filed 2026-02-24
2024-09-30-$88.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$128.00K
derived: sum of 2 quarters · filed 2025-11-04
$451.00K
10-Q · filed 2025-11-04
-$566.00K
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$40.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$539.00K
10-Q · filed 2025-08-05
-$478.00K
derived: sum of 3 quarters · filed 2026-02-24
-$624.00K
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$579.00K
10-Q · filed 2025-05-06
-$438.00K
derived: sum of 2 quarters · filed 2026-02-24
-$584.00K
derived: sum of 3 quarters · filed 2026-02-24
$437.00K
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.16M
derived: sum of 2 quarters · filed 2026-02-24
-$142.00K
derived: sum of 3 quarters · filed 2026-02-24
-$194.00K
10-K · filed 2026-02-24
2023-09-30-$146.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$875.00K
derived: sum of 2 quarters · filed 2024-11-05
$823.00K
10-Q · filed 2024-11-05
$793.00K
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$969.00K
10-Q · filed 2024-08-06
$939.00K
derived: sum of 3 quarters · filed 2025-02-25
$888.00K
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$52.00K
10-Q · filed 2024-05-07
-$82.00K
derived: sum of 2 quarters · filed 2025-02-25
-$133.00K
derived: sum of 3 quarters · filed 2025-02-25
-$10.92M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$81.00K
derived: sum of 2 quarters · filed 2025-02-25
-$10.87M
derived: sum of 3 quarters · filed 2025-02-25
-$2.57M
10-K · filed 2025-02-25
2022-09-30-$51.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$10.84M
derived: sum of 2 quarters · filed 2023-11-08
-$2.54M
10-Q · filed 2023-11-08
-$597.00K
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30-$10.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$2.49M
10-Q · filed 2023-08-08
-$546.00K
derived: sum of 3 quarters · filed 2024-02-27
-$597.00K
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$8.30M
10-Q · filed 2023-05-10
$10.24M
derived: sum of 2 quarters · filed 2024-02-27
$10.19M
derived: sum of 3 quarters · filed 2024-02-27
$10.14M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$1.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$1.89M
derived: sum of 2 quarters · filed 2024-02-27
$1.84M
derived: sum of 3 quarters · filed 2024-02-27
$1.79M
10-K · filed 2024-02-27
2021-09-30-$51.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$102.00K
derived: sum of 2 quarters · filed 2022-11-07
-$153.00K
10-Q · filed 2022-11-07
-$1.25M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$51.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$102.00K
10-Q · filed 2022-08-09
-$1.20M
derived: sum of 3 quarters · filed 2023-02-28
$891.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$51.00K
10-Q · filed 2022-05-09
-$57.00K
10-Q · filed 2021-05-11
-$1.15M
derived: sum of 2 quarters · filed 2023-02-28
$942.00K
derived: sum of 3 quarters · filed 2023-02-28
$936.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$1.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$993.00K
derived: sum of 2 quarters · filed 2023-02-28
$987.00K
derived: sum of 3 quarters · filed 2023-02-28
$981.00K
10-K · filed 2023-02-28
2020-09-30$2.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$2.08M
derived: sum of 2 quarters · filed 2021-11-08
$2.08M
10-Q · filed 2021-11-08
$2.07M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$12.00K
10-Q · filed 2020-08-12
-$18.00K
derived: sum of 3 quarters · filed 2022-02-28
-$25.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$6.00K
10-Q · filed 2021-05-11
-$12.00K
derived: sum of 2 quarters · filed 2022-02-28
-$19.00K
derived: sum of 3 quarters · filed 2022-02-28
-$24.00K
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$13.00K
derived: sum of 2 quarters · filed 2022-02-28
-$18.00K
derived: sum of 3 quarters · filed 2022-02-28
-$191.00K
10-K · filed 2022-02-28
2019-09-30-$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
-$12.00K
derived: sum of 2 quarters · filed 2020-11-10
-$185.00K
10-Q · filed 2020-11-10
2019-06-30-$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$178.00K
10-Q · filed 2020-08-12
2019-03-31-$173.00K
10-Q · filed 2020-05-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
NOVAVAX INC (NVAX)United States$1.748B-6.26